The registration for this event has passed. Check back soon for content you missed, post-event updates, as well as recommendations for future events you may be interested in.
Details
The 33rd Annual Lorne Cancer Conference 2021 will be held from the 11th - 13th February 2021 and will proceed as a “hybrid” event with face-to-face and virtual content delivery.
Lorne Cancer 2021 will explore in depth tumor immunology, genomics, molecular signaling, and lung and pancreatic cancers, and other key themes such as:
- single cell sequencing
- aneuploidy
- cell metabolism
- tumor-stroma interactions
- stem cell biology
- epigenetic regulation
Illumina is pleased to be gold sponsors of the 33rd Annual Lorne Cancer Conference 2021 in partnership with the University of Melbourne.
Illumina and the University of Melbourne are partnering affordable, scaleable next-generation sequencing with the research expertise, infrastructure, systems and analysis needed to implement genomics into routine clinical care.
Based in the Melbourne Biomedical Precinct, the collaborative, cross-disciplinary approach translates evidence-based advancements into the clinic, supporting local training and jobs.
The partnership, together with Invest Victoria, have also launched The Illumina-University of Melbourne Genomics Hub. To find out more about how the Hub will become a key driver in building workforces and businesses of the future, delivering first-hand, practical experience and fostering a pipeline of commercially focused genomics innovation projects visit this website.
- Date & Time
- 11 Feb. 2021 – 13 Feb. 2021
- Location
- Hybrid - Online and in person at the Mantra Lorne, Australia
- Australia
- Topic
- Cancer research, Oncology